80 studies found for:    "Tobacco, Smokeless" | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Retrospective Evaluation of CML Patients in the National Compassionate Program
Conditions: Chronic Myeloid Leukemia;   Philadelphia Positive
Intervention: Drug: Ponatinib
22 Recruiting Generalized Neonatal Screening of Severe Combined Immunodeficiencies
Condition: Severe Combined Immunodeficiency, Atypical
Intervention: Biological: SCID screening
23 Recruiting Thermic Effects of Some Scottish Plant Foods
Conditions: Diet Induced Thermogenesis;   Obesity Control
Interventions: Dietary Supplement: Control Meal;   Dietary Supplement: Berry Treatment;   Dietary Supplement: Sea Buckthorn Treatment;   Dietary Supplement: Wild Garlic Treatment
24 Recruiting Culturally Grounded Early Substance Use Prevention for American Indian Families
Condition: Substance Use
Interventions: Behavioral: Lakota Language enhancement;   Behavioral: Facebook Supplement;   Behavioral: Substance Use Resistance Skills
25 Recruiting Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Lactoflorene colesterolo;   Dietary Supplement: Placebo lactoflorene colesterolo
26 Recruiting Impact of Physiological, Lifestyle and Genetic Factors on Body Composition
Condition: Body Composition, Beneficial
Intervention:
27 Recruiting Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon
Condition: Ruptured Achilles Tendon
Interventions: Procedure: operative;   Procedure: non-operative
28 Recruiting Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
Conditions: Schizoaffective and Schizophreniform Disorders;   Schizophrenia
Interventions: Drug: Ondansetron;   Drug: Placebo
29 Recruiting Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: Crespine gel;   Drug: Intragel;   Drug: Crespine plus gel;   Drug: Monovisc
30 Recruiting Non Touch Technique for IUD Insertion
Condition: Contraception
Intervention: Device: intrauterine device TCu 380A
31 Recruiting PEG-INTERFERON FOR INACTIVE HBV CARRIERS
Conditions: Chronic Hepatitis, B Virus;   Carrier of Viral Hepatitis Type B
Intervention: Drug: Peginterferon Alfa-2A
32 Not yet recruiting Intracochlear Potentials: Volta Study
Condition: Hearing Loss
Interventions: Device: SA16 research software;   Device: CS19 (1.6.2)
33 Recruiting Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia;   Complete Hematologic Remission (CHR);   Persistent/Recurrent Minimal Residual Disease (MRD)
Intervention: Other: Autologous NK cells infusions
34 Recruiting REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
Conditions: Huntington Disease;   Huntington's Disease
Intervention:
35 Recruiting "AIDA" Protocol (LAP 0493)
Condition: Leukemia
Intervention: Drug: all-trans retinoic acid (ATRA)
36 Recruiting Riociguat in Scleroderma Associated Digital Ulcers
Conditions: Scleroderma;   Digital Ulcers
Interventions: Drug: Riociguat;   Drug: Placebo
37 Recruiting Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.
Condition: Phobia, Specific
Interventions: Drug: Valproic Acid;   Drug: Placebo;   Behavioral: Fear reactivation;   Behavioral: No fear reactivation
38 Recruiting "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
Condition: Leukemia, Lymphoblastic, Acute
Interventions: Procedure: Geriatric assessment adapted therapy;   Procedure: Stem cells autotransplantation
39 Recruiting MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate
Conditions: Untreated Philadelphia Positive Acute Lymphoblastic Leukemia;   De Novo;   Secondary;   Low-dose Corticosteroids Pretreatment
Interventions: Drug: Prephase PDN + CY;   Drug: Cycle 1 Induction;   Drug: Cycle 2 Induction / Early consolidation;   Drug: Cycle 3 Early consolidation;   Drug: Cycle 4 Consolidation;   Drug: Cycle 5 Consolidation;   Drug: Cycle 6 Consolidation;   Drug: Cycle 7 Consolidation;   Drug: Cycle 8 Reinduction;   Drug: Maintenance;   Procedure: Allogeneic SCT or Autologous SCT
40 Recruiting Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
Conditions: Philadelphia Positive;   BCR-ABL Positive;   Acute Lymphoblastic Leukemia
Intervention: Drug: Ponatinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.